Clear All
12250 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
00143-9549-10 00143-9549 Doxorubicin Hydrochloride Adriamycin 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous May 1, 1996 In Use
00069-3358-25 00069-3358 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Nov 11, 2024 In Use
00703-5043-01 00703-5043 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Sep 1, 1995 Mar 31, 2019 No Longer Used
00069-1441-04 00069-1441 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous May 16, 2013 Dec 31, 2017 No Longer Used
00069-0080-01 00069-0080 Mitoxantrone Hydrochloride Mitoxantrone Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracenedione Intravenous Dec 12, 2012 Dec 31, 2016 No Longer Used
00069-1340-02 00069-1340 Ondansetron Hydrochloride Ondansetron Hydrochloride 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous May 10, 2011 Jul 31, 2014 No Longer Used
52125-0574-14 52125-0574 Ondansetron Hydrochloride Ondansetron Hydrochloride 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Dec 5, 2013 Dec 5, 2014 No Longer Used
00574-0931-25 00574-0931 Doxorubicin hydrochloride Doxorubicin hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Oct 25, 2021 Apr 30, 2024 No Longer Used
59676-0966-02 59676-0966 doxorubicin hydrochloride Doxorubicin Hydrochloride liposome 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jun 26, 2017 Oct 31, 2020 No Longer Used
50090-2342-00 50090-2342 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Apr 6, 2016 Sep 30, 2018 In Use
70710-1896-06 70710-1896 Arsenic trioxide Arsenic trioxide 2.0 mg/mL Chemotherapy Miscellaneous Agent PML/RARa Intravenous Feb 28, 2023 In Use
51662-1469-01 51662-1469 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Dec 14, 2019 In Use
72603-0507-01 72603-0507 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Aug 1, 2025 In Use
00009-5091-01 00009-5091 Epirubicin Hydrochloride Ellence 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Sep 15, 1999 In Use
50742-0525-07 50742-0525 arsenic trioxide ARSENIC TRIOXIDE 2.0 mg/mL Chemotherapy Miscellaneous Agent PML/RARa Intravenous Jan 27, 2021 In Use
23155-0549-31 23155-0549 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Jun 15, 2012 In Use
23155-0378-42 23155-0378 Ondansetron Hydrochloride Ondansetron Hydrochloride 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Feb 19, 2014 Oct 11, 2019 In Use
52125-0334-40 52125-0334 Ondansetron Hydrochloride Ondansetron Hydrochloride 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Jun 14, 2013 Jun 15, 2013 No Longer Used
00069-0170-01 00069-0170 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Oct 29, 2011 Dec 31, 2017 No Longer Used
00409-1120-12 00409-1120 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Oct 14, 2011 May 1, 2019 In Use
45963-0733-57 45963-0733 Doxorubicin Hydrochloride Doxorubicin hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Nov 1, 2014 In Use
83270-0160-03 83270-0160 Ondansetron hydrochloride Ondansetron hydrochloride 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Sep 30, 2023 In Use
68001-0629-36 68001-0629 DOXORUBICIN HYDROCHLORIDE DOXORUBICIN HYDROCHLORIDE 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jan 7, 2025 In Use
16729-0297-83 16729-0297 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Oct 20, 2016 In Use
00641-6078-01 00641-6078 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Dec 26, 2006 In Use

Found 12250 results — Export these results